|
1. Garcia Casado J, Janda J, Wei J, Chapatte L, Colombetti S, Alves P, Ritter G, Ayyoub M, Valmori D, Chen W, and Levy F. Lentivector immunization induces tumor antigen-specific B and T cell responses in vivo. Eur J Immunol. 38(7):1867-1876 (2008)
2. Ebert LM, Tan B, Browning J, Svobodova S, Russell, SE, Kirkpatrick N, Gedye C, Moss D, Ng S, MacGregor D, Davis ID, Cebon J, Chen W. The regulatory T cell-associated transcription factor FoxP3 is expressed by tumor cells. Cancer Res 68(8):3001-9 (2008)
3. Chen W, McCluskey J. Immunodominance and immunodomination: critical factors in developing effective CD8(+) T-cell-based cancer vaccines. Adv Cancer Res.;95:203-47 (2006)
4. Pang, K; Wei, J and Chen, W. Dynamic quantification of MHC class I-peptide presentation to CD8+ T cells via intracellular cytokine staining.J Immunol Methods.;311(1-2):12-8. (2006)
5. La Gruta NL, Kedzierska K, Pang KC, Webby R, Davenport M, Chen W, Turner SJ, Doherty PC. A virus specific CD8+ T cell immunodominance hierarchy determined by precursor frequencies and antigen dose. Proc Natl Acad Sci USA. 103(4):994-9 (2006)
6. Jackson H, Dimopoulos N, Mifsud NA, Tai TY, Chen Q, Svobodova S, Browning J, Luescher I, Stockert L, Old LJ, Davis ID, Cebon J, Chen W. Striking immunodominance hierarchy of naturally occurring CD8+ and CD4+ T cell responses to tumor antigen NY-ESO-1. J Immunol., 176(10):5908-17 (2006)
Click Here For More
|